Organogenesis Holdings Inc (ORGO) - News Archive

Organogenesis Provides Promising Update on Second Phase 3 ReNu Study in Innovative Pain Management In a recent press release, Organogenesis Holdings Inc. has provided an important update regarding its ongoing Phase 3 cl...

In an era where healthcare innovation is paramount, Organogenesis Holdings Inc. finds itself at a critical crossroads. As the company pushes for a delay in the Centers for Medicare & Medicaid Services (CMS) Local Covera...

In recent developments, Organogenesis Holdings Inc. has been actively involved in promoting data-driven policies for Local Coverage Determination (LCD), positioning itself at the forefront of collaborative efforts aimed...

In a strategic maneuver to enhance its operational capacity and shareholder value, Organogenesis Holdings Inc. recently announced a plan to utilize net proceeds from its forthcoming financial dealings to fund various gr...

In a landmark announcement for the field of regenerative medicine, Organogenesis Holdings Inc. (Nasdaq: ORGO), renowned for its pioneering work in advanced wound care and surgical solutions, has reported a favorable out...

Diabetic foot ulcers (DFUs) pose a significant challenge to healthcare systems around the globe, affecting thousands of patients annually and often leading to increased morbidity, amputations, and healthcare costs. In a...

CANTON, Mass., Aug. 8, 2024 - Organogenesis Holdings Inc. (Nasdaq: ORGO), a frontrunner in regenerative medicine dedicated to the advanced wound care and surgical sports medicine markets, has announced a significant dev...

Organogenesis Holdings Inc., a prominent regenerative medicine company specializing in Advanced Wound Care and Surgical and Sports Medicine solutions, recently announced the successful accomplishment of its Phase 3 clin...